T1	Person 21 24	Raf
T2	Person 25 28	Mek
T3	Person 29 32	Erk
T4	Person 44 50	kinase
T5	Person 249 257	oncogene
T6	Person 265 293	non-small celllung carcinoma
T7	Person 295 300	NSCLC
T8	Person 326 329	Erk
T9	Person 330 336	kinase
T10	Person 355 360	K-Ras
T11	Person 431 437	Erk1/2
T12	Person 454 471	tumor development
T13	Person 489 498	lethality
T14	Person 502 512	adult mice
T15	Person 527 533	Mek1/2
T17	Person 666 669	RAs
T18	Person 734 739	A-Raf
T19	Person 752 758	c-Raf.
T20	Person 741 746	B-Raf
T16	Person 1189 1201	mutant tumor
T21	Person 1235 1253	anti-tumor effects
T22	Person 1261 1271	inhibition
T23	Person 1444 1458	adenocarcinoma
T24	Person 1486 1495	tamoxifen
T25	Person 1466 1482	treatment method
